DE3682160D1 - 2-substituierte chinoline. - Google Patents

2-substituierte chinoline.

Info

Publication number
DE3682160D1
DE3682160D1 DE8686307785T DE3682160T DE3682160D1 DE 3682160 D1 DE3682160 D1 DE 3682160D1 DE 8686307785 T DE8686307785 T DE 8686307785T DE 3682160 T DE3682160 T DE 3682160T DE 3682160 D1 DE3682160 D1 DE 3682160D1
Authority
DE
Germany
Prior art keywords
substituted
alkyl
unsubstituted
radical
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686307785T
Other languages
English (en)
Inventor
Robert N Young
Robert Zamboni
Serge Leger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Application granted granted Critical
Publication of DE3682160D1 publication Critical patent/DE3682160D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
DE8686307785T 1985-10-16 1986-10-08 2-substituierte chinoline. Expired - Lifetime DE3682160D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78794285A 1985-10-16 1985-10-16

Publications (1)

Publication Number Publication Date
DE3682160D1 true DE3682160D1 (de) 1991-11-28

Family

ID=25142975

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686307785T Expired - Lifetime DE3682160D1 (de) 1985-10-16 1986-10-08 2-substituierte chinoline.

Country Status (7)

Country Link
EP (1) EP0219308B1 (de)
JP (1) JPS6293277A (de)
AT (1) ATE68789T1 (de)
CA (1) CA1298838C (de)
DE (1) DE3682160D1 (de)
DK (1) DK487586A (de)
ES (1) ES2002037A6 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962203A (en) * 1985-06-18 1990-10-09 Merck Frost Canada, Inc. 2-substituted quinolines useful as leukotriene antagonists
EP0271287A3 (de) * 1986-12-11 1990-06-13 Merck Frosst Canada Inc. Chinolindicarbonsäuren und ihre Amide
AU1549788A (en) * 1987-03-18 1988-10-10 American Home Products Corporation Sulfonylcarboxamides
JPS63258854A (ja) * 1987-04-16 1988-10-26 Mitsubishi Kasei Corp カルボキシスチレン誘導体およびそれを有効成分とする薬剤
US4920131A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
US5385912A (en) * 1991-03-08 1995-01-31 Rhone-Poulenc Rorer Pharmaceuticals Inc. Multicyclic tertiary amine polyaromatic squalene synthase inhibitors
US5157040A (en) * 1991-04-05 1992-10-20 Merck & Co., Inc. Substituted quinolines as angiotensin ii antagonists
US5455260A (en) * 1993-05-21 1995-10-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aliphatic amino bis-aryl squalene synthase inhibitors
US5508408A (en) * 1993-09-10 1996-04-16 Ciba-Geigy Corporation Quinoline compound
US5561143A (en) * 1995-01-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aliphatic amino bis-aryl squalene synthase inhibitors
TWI311133B (en) * 2001-04-20 2009-06-21 Eisai R&D Man Co Ltd Carboxylic acid derivativeand the salt thereof
JPWO2003016265A1 (ja) 2001-08-17 2004-12-02 エーザイ株式会社 環状化合物およびｐｐａｒアゴニスト

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB321738A (en) * 1928-08-21 1929-11-21 Ig Farbenindustrie Ag Process for the manufacture of phenylcarboxylic acid compounds
DE2735919A1 (de) * 1977-08-10 1979-02-22 Boehringer Sohn Ingelheim Neue 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren
CA1134828A (en) * 1978-12-28 1982-11-02 Tadao Tanouchi Pyridine derivatives
US4325959A (en) * 1979-08-09 1982-04-20 The Dow Chemical Company Hypoglycemic 4-(((1,3,4, thiadiazolyl)thio)methyl)benzoic acids, ester and amides
US4464533A (en) * 1982-11-08 1984-08-07 Ppg Industries, Inc. Herbicidally active quinoline or quinoxaline benzoate derivatives
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
IE58870B1 (en) * 1985-03-08 1993-11-17 Leo Pharm Prod Ltd Pyridine derivatives
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
JPH06752B2 (ja) * 1985-04-24 1994-01-05 正木 長谷川 非対称ジオレフイン化合物

Also Published As

Publication number Publication date
EP0219308B1 (de) 1991-10-23
DK487586A (da) 1987-04-17
ATE68789T1 (de) 1991-11-15
CA1298838C (en) 1992-04-14
EP0219308A3 (en) 1987-10-14
ES2002037A6 (es) 1988-07-01
DK487586D0 (da) 1986-10-13
EP0219308A2 (de) 1987-04-22
JPS6293277A (ja) 1987-04-28

Similar Documents

Publication Publication Date Title
DE3682160D1 (de) 2-substituierte chinoline.
ES8801209A1 (es) Un procedimiento para la preparacion de quinolinas 2-sustituidas.
ES2062395T3 (es) Nuevos compuestos de bencimidazol y su uso.
ATE63553T1 (de) Chinazolindione und pyridopyrimidindione.
NO820264L (no) Fremgangsmaate for fremstilling av 2-penemforbindelser
MX5680E (es) Procedimiento para la preparacion de 2-(2-alcoxietil)-2'-hidroxi-6,7-benzomorfanos
ES467154A1 (es) Procedimiento para la preparacion de materiales organicos aclarados opticamente
SE8703886L (sv) Nya mellanprodukter anvendbara for framstellning av 4-hydroxi-3-kinolinkarboxylsyraderivat
FI803654L (fi) Nya substituerade 2-fenylaminoimidazoliner-(2) deras syraadditionssalter dessa foereningar innehaollande laekemedel och deras framstaellningsfoerfarande
DE3068456D1 (en) 2-(n-(2-fluoro-6-bromophenyl)-n-(thiemyl-2-methyl)-amino)-2-imidazoline, its addition salts, pharmaceutical compositions containing them and processes for their preparation
JPS5692873A (en) Imidazoline compound
ATE66919T1 (de) Thiophen-derivate.
PT69804A (de) Neue imidazo/1,2-a/imidazole deren saureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
CH610877A5 (en) Process for the preparation of o-(2,6-dichloroanilino)phenylacetic acid and of the addition salts of this acid
ES8307812A1 (es) Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo.
JPS5572186A (en) Dibenzothiepin derivative and its preparation
JPS5479248A (en) (2s, 3r)-3-amino-2-hydroxy-4-p-hydroxyphenylbutyric acid
JPS5581869A (en) Substituted benzoic acid amide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee